| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. | Director | Restricted Stock Units | 6.33K | $53.6K | $8.46 | 28 Mar 2025 | Direct |
| Avalo Therapeutics, Inc. | Director | Common Stock | 3.17K | $26.8K | $8.46 | 28 Mar 2025 | Direct |
| Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20.1K | 17 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 18 Jun 2025, 16:44 |
| AVTX | Avalo Therapeutics, Inc. | 28 Mar 2025 | 2 | $0 | 4 | Director | 01 Apr 2025, 16:44 |
| AVTX | Avalo Therapeutics, Inc. | 13 Aug 2024 | 2 | $0 | 4 | Director | 14 Aug 2024, 16:27 |
| AVTX | Avalo Therapeutics, Inc. | 28 Mar 2024 | 0 | $0 | 3 | Director | 03 Apr 2024, 16:07 |